Works matching IS 03065251 AND DT 1995 AND VI 40 AND IP 3
1
- British Journal of Clinical Pharmacology, 1995, v. 40, n. 3, p. 217, doi. 10.1111/j.1365-2125.1995.tb05776.x
- Rostami‐Hodjegan, A.;
- Lennard, L.;
- Lilleyman, JS
- Article
2
- British Journal of Clinical Pharmacology, 1995, v. 40, n. 3, p. 289, doi. 10.1111/j.1365-2125.1995.tb05789.x
- Martin Arias, LH;
- Carvajal, A.;
- Martin De Diego, I.;
- Abajo, F.
- Article
3
- British Journal of Clinical Pharmacology, 1995, v. 40, n. 3, p. 270, doi. 10.1111/j.1365-2125.1995.tb00001.x
- Ahonen, Jouni;
- Olkkola, Klaus T.;
- Neuvonen, Pertti J.
- Article
4
- British Journal of Clinical Pharmacology, 1995, v. 40, n. 3, p. 287, doi. 10.1111/j.1365-2125.1995.tb05788.x
- Berndt, A.;
- Hoffmann, C.;
- Richter, K.;
- Oertel, R.;
- Vierkant, A.;
- Siegmund, W.
- Article
5
- British Journal of Clinical Pharmacology, 1995, v. 40, n. 3, p. 199, doi. 10.1111/j.1365-2125.1995.tb05775.x
- Article
6
- British Journal of Clinical Pharmacology, 1995, v. 40, n. 3, p. 223, doi. 10.1111/j.1365-2125.1995.tb05777.x
- Coupland, NJ;
- Bailey, JE;
- Glue, P.;
- Nutt, DJ
- Article
7
- British Journal of Clinical Pharmacology, 1995, v. 40, n. 3, p. 283, doi. 10.1111/j.1365-2125.1995.tb05787.x
- Sharara, AM;
- Higham, MA;
- Spanevello, A.;
- Ind, PW
- Article
8
- British Journal of Clinical Pharmacology, 1995, v. 40, n. 3, p. 281, doi. 10.1111/j.1365-2125.1995.tb05786.x
- Higham, MA;
- Sharara, AM;
- Magee, RP;
- Ind, PW
- Article
9
- British Journal of Clinical Pharmacology, 1995, v. 40, n. 3, p. 277, doi. 10.1111/j.1365-2125.1995.tb05785.x
- Schoors, DF;
- Smet, M.;
- Reiss, T.;
- Margolskee, D.;
- Cheng, H.;
- Larson, P.;
- Amin, R.;
- Somers, G.
- Article
10
- British Journal of Clinical Pharmacology, 1995, v. 40, n. 3, p. 273, doi. 10.1111/j.1365-2125.1995.tb05784.x
- Cawello, W.;
- Leonhardt, A.;
- Schweer, H.;
- Seyberth, HW;
- Bonn, R.;
- Lomeli, AL
- Article
11
- British Journal of Clinical Pharmacology, 1995, v. 40, n. 3, p. 266, doi. 10.1111/j.1365-2125.1995.tb05783.x
- Bannwarth, B.;
- Lapicque, F.;
- Pehourcq, F.;
- Gillet, P.;
- Schaeverbeke, T.;
- Laborde, C.;
- Dehais, J.;
- Gaucher, A.;
- Netter, P.
- Article
12
- British Journal of Clinical Pharmacology, 1995, v. 40, n. 3, p. 263, doi. 10.1111/j.1365-2125.1995.tb05782.x
- Eisenhofer, G.;
- Friberg, P.;
- Goldstein, DS;
- Esler, M.
- Article
13
- British Journal of Clinical Pharmacology, 1995, v. 40, n. 3, p. 253, doi. 10.1111/j.1365-2125.1995.tb05781.x
- Dingemanse, J.;
- Jorga, K.;
- Zurcher, G.;
- Schmitt, M.;
- Sedek, G.;
- Prada, M.;
- Brummelen, P.
- Article
14
- British Journal of Clinical Pharmacology, 1995, v. 40, n. 3, p. 245, doi. 10.1111/j.1365-2125.1995.tb05780.x
- Ferro, A.;
- Longmore, J.;
- Hill, RG;
- Brown, MJ
- Article
15
- British Journal of Clinical Pharmacology, 1995, v. 40, n. 3, p. 237, doi. 10.1111/j.1365-2125.1995.tb05779.x
- Lijesen, GK;
- Theeuwen, I.;
- Assendelft, WJ;
- Wal, G.
- Article
16
- British Journal of Clinical Pharmacology, 1995, v. 40, n. 3, p. 231, doi. 10.1111/j.1365-2125.1995.tb05778.x
- Oo, CY;
- Kuhn, RJ;
- Desai, N.;
- Wright, CE;
- McNamara, PJ
- Article